Open3.940 | Close4.180 |
Vol / Avg.14.059K / 8.316K | Mkt Cap7.081M |
Day Range3.890 - 4.190 | 52 Wk Range3.350 - 30.000 |
Finch Therapeutics Gr Stock (NASDAQ: FNCH) stock price, news, charts, stock research, profile.
Open3.940 | Close4.180 |
Vol / Avg.14.059K / 8.316K | Mkt Cap7.081M |
Day Range3.890 - 4.190 | 52 Wk Range3.350 - 30.000 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-05-12 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | 7.00 | 7.00 |
2023-04-04 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Lowers | 17.00 | 7.00 |
2022-08-09 | HC Wainwright & Co. | Vernon Bernardino | Initiates Coverage On | Buy | Announces | - | 17.00 |
2022-04-04 | Jefferies | Chris Howerton | Maintains | Buy | Lowers | 29.00 | 17.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
FNCH | Finch Therapeutics Gr | 7.04% | 7.1M |
ERNA | Eterna Therapeutics | 16.95% | 7.5M |
ALZN | Alzamend Neuro | 1.92% | 6.9M |
ADXN | Addex Therapeutics | 3.45% | 6M |
BRTX | BioRestorative Therapies | 7.95% | 8.9M |
You can purchase shares of Finch Therapeutics Gr (NASDAQ: FNCH) through any online brokerage.
Other companies in Finch Therapeutics Gr’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Alzamend Neuro (NASDAQ:ALZN), Addex Therapeutics (NASDAQ:ADXN), BioRestorative Therapies (NASDAQ:BRTX) and Galera Therapeutics (NASDAQ:GRTX).
The latest price target for Finch Therapeutics Gr (NASDAQ: FNCH) was reported by HC Wainwright & Co. on Friday, May 12, 2023. The analyst firm set a price target for 7.00 expecting FNCH to rise to within 12 months (a possible 58.73% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Finch Therapeutics Gr (NASDAQ: FNCH) is $4.41 last updated December 4, 2023 at 9:15 PM UTC.
There is no dividend information for Finch Therapeutics Gr.
Finch Therapeutics Gr’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Finch Therapeutics Gr.
Finch Therapeutics Gr is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.